Nisa Investment Advisors
CGON icon

Nisa Investment Advisors’s CG Oncology CGON Stock Holding History

Nisa Investment Advisors’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$113K Buy
1,595
+307
+24% +$20.1K ﹤0.01% 1483
2026
Q1 		$87.2K Buy
1,288
+559
+77% +$31.7K ﹤0.01% 1477
2025
Q4 		$30.3K Buy
729
+6
+0.8% +$248 ﹤0.01% 1788
2025
Q3 		$29.1K Sell
723
-26
-3% -$756 ﹤0.01% 1828
2025
Q2 		$19.5K Buy
749
+699
+1,398% +$16.8K ﹤0.01% 1948
2025
Q1 		$1.23K Sell
50
-19
-28% -$534 ﹤0.01% 2582
2024
Q4 		$1.98K Buy
69
+1
+1% +$34 ﹤0.01% 2489
2024
Q3 		$2.57K Buy
68
+22
+48% +$771 ﹤0.01% 2348
2024
Q2 		$1.45K Buy
46
+41
+820% +$1.42K ﹤0.01% 2431
2024
Q1 		$220 Buy
+5
New +$204 ﹤0.01% 2625

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nisa Investment Advisors's CGON Position: Q2 2026 in Review

Nisa Investment Advisors increased its CG Oncology (CGON) stake by 24% in Q2 2026, buying an estimated $20.1K and bringing the position to 1,595 shares worth $113K. The position accounts for ﹤0.01% of the portfolio, ranked #1483.

Nisa Investment Advisors first reported a position in CGON in Q1 2024 and has held it in 10 quarters since. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Nisa Investment Advisors held 1,595 shares of CG Oncology worth $113K as of Q2 2026.
  • Nisa Investment Advisors bought 307 CG Oncology shares in Q2 2026, an estimated $20.1K.
  • CG Oncology made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1483 holding.
  • Nisa Investment Advisors first reported a position in CG Oncology in Q1 2024 and has held it in 10 quarters since.
  • 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.